Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hexokinase 2 (HK2) is an enzyme that catalyzes the first step of glycolysis, the phosphorylation of glucose to glucose-6-phosphate. It plays a critical role in cellular energy metabolism and is often overexpressed in cancer cells, contributing to the Warburg effect. HK2's localization to the outer mitochondrial membrane (OMM) via binding to VDAC provides a link between glycolysis and oxidative phosphorylation and confers anti-apoptotic properties. Targeting HK2 is explored as a potential anti-cancer strategy.
Inhibition of HK2 activity, Disruption of HK2-VDAC interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hexokinase 2 (HK2).